BRISTOL MYERS SQUIBB WEBSITE BRANDING, SOCIAL, REPORT & MORE
Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines. With a strong commitment to scientific research, the company aims to improve patient outcomes and drive advancements in healthcare. The annual thesis required a take on the report visually for kidney cancer patients and below are the results.
FRIENDLY & A HOPEFUL PRESENCE
VISUAL STORYTELLING
KIDNEY CANCER PATIENTSBristol Myers Squibb is dedicated to improving outcomes for kidney cancer patients through innovative treatments. The company has developed therapies aimed at both advanced and early-stage kidney cancer, including targeted therapies and immuno-oncology treatments that help the immune system fight cancer. Their research and development efforts focus on providing new treatment options to increase survival rates and improve the quality of life for patients with kidney cancer.
* ALL DATA are from 2019
VISUALS HIGHLIGHTING THE RESEARCHThe focus was to give a friendly explanation from the research papers on kidney cancer treatments for users to read through and feel safer about by visually simplifying complex data and making it more accessible and engaging.
Through infographics, data visualisations and social designs this approach has helped convey key insights, track progress and highlight the impact of new treatments all while making the information more compelling and memorable for a wider audience.
Brian Lamon, BMS VP
To highlight kidney cancer patients via BMS’ research
Created a printed doc of the research papers along with some social materials.
The printed work was sent to multiple hospitals around the UK.